2023
DOI: 10.1038/s41467-023-37092-w
|View full text |Cite
|
Sign up to set email alerts
|

Genomic characterization of DICER1-associated neoplasms uncovers molecular classes

Abstract: DICER1 syndrome is a tumor predisposition syndrome that is associated with up to 30 different neoplastic lesions, usually affecting children and adolescents. Here we identify a group of mesenchymal tumors which is highly associated with DICER1 syndrome, and molecularly distinct from other DICER1-associated tumors. This group of DICER1-associated mesenchymal tumors encompasses multiple well-established clinicopathological tumor entities and can be further divided into three clinically meaningful classes designa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 82 publications
0
14
0
Order By: Relevance
“…Regarding the nosology that should be used to classify our case, some authors have proposed to use a broad term of “ DICER1 ‐mutated sarcomas” 13,27 as these tumors commonly combine rhabdomyosarcomatous and spindle cell features and share a similar molecular signature 28 . Some morphological features seem recurrent if not constant, including the presence of foci of cartilage, 14,18,20 of teratoid glandular/epithelial elements as highlighted in our case.…”
Section: Discussionmentioning
confidence: 79%
“…Regarding the nosology that should be used to classify our case, some authors have proposed to use a broad term of “ DICER1 ‐mutated sarcomas” 13,27 as these tumors commonly combine rhabdomyosarcomatous and spindle cell features and share a similar molecular signature 28 . Some morphological features seem recurrent if not constant, including the presence of foci of cartilage, 14,18,20 of teratoid glandular/epithelial elements as highlighted in our case.…”
Section: Discussionmentioning
confidence: 79%
“…S4E). Alternatively, human tumors may harness other oncogenic signaling pathways or growth factors, such as RAS/MAP kinase; indeed, RAS pathway genes are the most frequently mutated genes in DICER1-related tumors after TP53 [87][88][89]. Future studies will be needed to identify the mitogenic signaling pathways used in human pineoblastomas.…”
Section: Discussionmentioning
confidence: 99%
“…D ICER1 syndrome is a pleiotropic cancer predisposition syndrome caused by germline pathogenic variants (GPVs) in DICER1. 1,2 The phenotype includes a diverse type of tumors (eg, pleuropulmonary blastoma (PPB), cystic nephroma, Sertoli-Leydig cell tumor, and embryonic rhabdomyosarcoma), but many of them appear to share unifying pathologic features, 3,4 which is further supported by methylation data showing that DIC-ER1-associated sarcomas arising from different sites cluster together 5 . For the most part, DICER1-associated tumors are characterized by a loss of function (LOF) variant on 1 allele and an acquired somatic mutation on the other allele that affects nucleotides encoding for the catalytic RNase IIIb domain of DICER1.…”
mentioning
confidence: 93%